Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biomedicine & Biotechnology|May 5, 2011
Functions of MDMX in the modulation of the p53-responseKristiaan Lenos, Aart G Jochemsen
Biological Chemistry|June 13, 2018
Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3Neha M Sahasrabudhe, Kristiaan Lenos, Joost C van der Horst, et al.
The Journal of Biological Chemistry|December 17, 2008
c-Abl phosphorylates Hdmx and regulates its interaction with p53Valentina Zuckerman, Kristiaan Lenos, Grzegorz M Popowicz, et al.
European Journal of Immunology|May 19, 2026
Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic SiteIrene van der Haar Àvila, Kristiaan Lenos, Victor Lorrain, et al.
Molecular Cancer|September 14, 2011
Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblastsKristiaan Lenos, Job de Lange, Amina F A S Teunisse, et al.
Cancer Research|June 16, 2012
Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancerKristiaan Lenos, Anna M Grawenda, Kirsten Lodder, et al.
Oncotarget|July 15, 2015
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patientsKristiaan Lenos, Jeroen A C M Goos, Ilona M Vuist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal MetastasisChin-Ann Johnny Ong, Joseph J Zhao, Ying Liu, et al.
Pageof 1